Open Access. Powered by Scholars. Published by Universities.®
- Discipline
- Publication
- Publication Type
- File Type
Articles 1 - 3 of 3
Full-Text Articles in Medicine and Health Sciences
Caregiver Strategy Use To Contend With Cognitive And Functional Decline In Persons With Dementia , Laura N. Gitlin, Marie P. Dennis, Walter W. Hauck, Laraine Winter, Sandy Schinfeld
Caregiver Strategy Use To Contend With Cognitive And Functional Decline In Persons With Dementia , Laura N. Gitlin, Marie P. Dennis, Walter W. Hauck, Laraine Winter, Sandy Schinfeld
Center for Applied Research on Aging and Health Research Papers
No abstract provided.
High-Field 19.6 T 27Al Solid-State Mas Nmr Of In Vitro Aluminated Brain Tissue, Pamela L. Bryant, Walter J. Lukiw, Zhehong Gan, Randall W. Hall, Leslie G. Butler
High-Field 19.6 T 27Al Solid-State Mas Nmr Of In Vitro Aluminated Brain Tissue, Pamela L. Bryant, Walter J. Lukiw, Zhehong Gan, Randall W. Hall, Leslie G. Butler
Randall W. Hall
Adjusting For Non-Ignorable Verification Bias In Clinical Studies For Alzheimer’S Disease, Xiao-Hua Zhou, Pete Castelluccio
Adjusting For Non-Ignorable Verification Bias In Clinical Studies For Alzheimer’S Disease, Xiao-Hua Zhou, Pete Castelluccio
UW Biostatistics Working Paper Series
A common problem for comparing the relative accuracy of two screening tests for Alzheimer’s disease (D) in a two-stage design study is verification bias. If the verification bias can be assumed to be ignorable, Zhou and Higgs (2000) have proposed a maximum likelihood approach to compare the relative accuracy of screening tests in a two-stage design study. However, if the verification mechanism also depends on the unobserved disease status, the ignorable assumption does not hold. In this paper, we discuss how to use a profile likelihood approach to compare the relative accuracy of two screening tests for AD without assuming …